retatrutide type 2 diabetes trial 2024 Effects of on body composition in people with diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised Retatrutide Availability & Timeline |

Weight loss in week 1 is usually minimal (1-3 pounds, often water)

Why is slow titration important for GLP-1 medications

The drug lowered levels of 2-aminoadipic acid (2-AAA), triglycerides (TGs) enriched in short- and saturated-chain fatty acids, and urate in both trial populations, while 2-hydroxybutyrate (2-HB) was lowered more robustly in the T2D cohort and mainly by week 48 in the obesity trial

Choosing Between Semaglutide and Tirzepatide for Microdosing From a pharmacology standpoint, semaglutide is a pure GLP-1 receptor agonist , while tirzepatide is a dual GIP/GLP-1 agonist that activates both GIP and GLP-1 receptors.[2,4] That dual mechanism likely contributes to tirzepatides strong weight-loss results at full doses compared with semaglutide in head-to-head and indirect comparisons.[2,7] In the context of microdosing: Some clinicians and patients feel that microdosing tirzepatide provides robust appetite control even at relatively low doses, though this is based largely on real-world experience rather than large trials

PMID: 34532853

For timeline-specific guides, see tirzepatide weight loss timeline , semaglutide results week by week , and when you start losing weight on semaglutide